Elisa Bergaggio
- MEDICINA MOLECOLARE
- Dottorato: 31° ciclo
- Matricola: 725884
Attività di ricerca
To identify genes and pathways mediating proteasome inhibitors resistance in multiple myeloma.
Scarfò I, Pellegrino E, Mereu E, Kwee I, Agnelli L, Bergaggio E, Garaffo G, Vitale N, Caputo M, Machiorlatti R, Circosta P, Abate F, Barreca A, Novero D, Mathew S, Rinaldi A, Tiacci E, Serra S, Deaglio S, Neri A, Falini B, Rabadan R, Bertoni F, Inghirami G, Piva R, European T-Cell Lymphoma Study Group. Identification of a new subclass of ALK negative ALCL expressing aberrant levels of ERBB4 transcripts. Blood 2016 vol: 127 (2) pp: 221-32.
Scarfò I, Pellegrino E, Mereu E, Kwee I, Agnelli L, Bergaggio E, Garaffo G, Vitale N, Caputo M, Machiorlatti R, Circosta P, Abate F, Barreca A, Novero D, Mathew S, Rinaldi A, Tiacci E, Serra S, Deaglio S, Neri A, Falini B, Rabadan R, Bertoni F, Inghirami G, Piva R. "The Impact of Transcriptional Profiling on the Molecular Classification of Anaplastic Large Cell Lymphoma". Hematological Malignancies: from Mechanisms to Therapy, March 9-12, 2016 Milan.
“Enabling technologies in 3D cancer organoids” Torino March 8/9, 2016.
“Guido Tarone study day” Torino May 21, 2016.
Giuliani N. “Inflammation and osteolysis in myeloma microenvironment” Torino June 15, 2016.
Massaia M. “Immune suppression and microenvironment in human myeloma: lessons from Vɣ9Vδ2 T cells” Torino July 07, 2016.